{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:17:58Z","timestamp":1793459878934,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Gaucher disease (GD) is caused by a deficiency of \u03b2-glucocerebrosidase, encoded by\n                      <jats:italic>GBA<\/jats:italic>\n                      . Haplotype analyses previously demonstrated founder effects for particular\n                      <jats:italic>GBA<\/jats:italic>\n                      mutations in Ashkenazi Jewish and French-Canadian populations. This study aimed to investigate the clinical characteristics and mutation spectrum of\n                      <jats:italic>GBA<\/jats:italic>\n                      in Korean GD patients and to identify founder effect of\n                      <jats:italic>GBA<\/jats:italic>\n                      p.G85E in non-neuronopathic GD patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study cohort included 62 GD patients from 58 unrelated families. Among them, 18 patients from 17 families harbored the p.G85E mutation. Haplotype analysis was performed for 9 probands and their parents for whom DNA samples were available. In 58 unrelated probands, the\n                      <jats:italic>GBA<\/jats:italic>\n                      mutation p.L483P was the most common (30\/116 alleles, 26%), followed by p.G85E (16%), p.F252I (13%), and p.R296Q (9%). The median age at diagnosis of the 18 patients harboring the p.G85E mutation was 3.8 (range 1.2\u201357) years. No patients developed neurological symptoms during follow-up periods of 2.2\u201320.3 (median 13.9) years. The size of the shared haplotype containing\n                      <jats:italic>GBA<\/jats:italic>\n                      p.G85E was 732 kbp, leading to an estimated age of 3075\u00a0years.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The\n                      <jats:italic>GBA<\/jats:italic>\n                      p.G85E mutation, which appears to be neuroprotective despite producing distinctive visceromegaly and skeletal symptoms, exhibited a potential founder effect in Korean GD patients.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-020-01597-0","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T07:03:19Z","timestamp":1605078199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The GBA p.G85E mutation in Korean patients with non-neuronopathic Gaucher disease: founder and neuroprotective effects"],"prefix":"10.1186","volume":"15","author":[{"given":"Yoo-Mi","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ho","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gu-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Bae","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Min","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong Kun","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Hyuk","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Hee","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8615-186X","authenticated-orcid":false,"given":"Han-Wook","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,11]]},"reference":[{"key":"1597_CR1","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","volume":"372","author":"GA Grabowski","year":"2008","unstructured":"Grabowski GA. Phenotype, diagnosis, and treatment of Gaucher\u2019s disease. Lancet. 2008;372:1263\u201371.","journal-title":"Lancet"},{"key":"1597_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/10245332.2016.1240391","volume":"22","author":"L Nalysnyk","year":"2017","unstructured":"Nalysnyk L, Rotella P, Simeone JC, Hamed A, Weinreb N. Gaucher disease epidemiology and natural history: a comprehensive review of the literature. Hematology. 2017;22:65\u201373.","journal-title":"Hematology"},{"key":"1597_CR3","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/jimd.12235","volume":"43","author":"R Schiffmann","year":"2020","unstructured":"Schiffmann R, Sevigny J, Rolfs A, Davies EH, Goker-Alpan O, Abdelwahab M, et al. The definition of neuronopathic Gaucher disease. J Inherit Metab Dis. 2020;43:1056\u20139.","journal-title":"J Inherit Metab Dis"},{"key":"1597_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bcmd.2010.07.010","volume":"46","author":"SY Jeong","year":"2011","unstructured":"Jeong SY, Park SJ, Kim HJ. Clinical and genetic characteristics of Korean patients with Gaucher disease. Blood Cells Mol Dis. 2011;46:11\u20134.","journal-title":"Blood Cells Mol Dis"},{"key":"1597_CR5","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/BF00209497","volume":"95","author":"H Ida","year":"1995","unstructured":"Ida H, Iwasawa K, Kawame H, Rennert OM, Maekawa K, Eto Y. Characteristics of gene mutations among 32 unrelated Japanese Gaucher disease patients: absence of the common Jewish 84GG and 1226G mutations. Hum Genet. 1995;95:717\u201320.","journal-title":"Hum Genet"},{"key":"1597_CR6","first-page":"72","volume":"12","author":"HN Baris","year":"2014","unstructured":"Baris HN, Cohen IJ, Mistry PK. Gaucher disease: the metabolic defect, pathophysiology, phenotypes, and natural history. Pediatr Endocrinol Rev. 2014;12:72\u201381.","journal-title":"Pediatr Endocrinol Rev"},{"key":"1597_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000440865","volume":"83","author":"A Dandana","year":"2016","unstructured":"Dandana A, Ben Khelifa S, Chahed H, Miled A, Ferchichi S. Gaucher disease: clinical, biological and therapeutic aspects. Pathobiology. 2016;83:13\u201323.","journal-title":"Pathobiology"},{"key":"1597_CR8","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","volume":"160","author":"J Charrow","year":"2000","unstructured":"Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, Pastores G, et al. The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease. Arch Intern Med. 2000;160:2835\u201343.","journal-title":"Arch Intern Med"},{"key":"1597_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3345\/kjp.2012.55.2.48","volume":"55","author":"JY Lee","year":"2012","unstructured":"Lee JY, Lee BH, Kim GH, Jung CW, Lee J, Choi JH, et al. Clinical and genetic characteristics of Gaucher disease according to phenotypic subgroups. Korean J Pediatr. 2012;55:48\u201353.","journal-title":"Korean J Pediatr"},{"key":"1597_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.bcmd.2006.11.003","volume":"38","author":"FY Choy","year":"2007","unstructured":"Choy FY, Zhang W, Shi HP, Zay A, Campbell T, Tang N, et al. Gaucher disease among Chinese patients: review on genotype\/phenotype correlation from 29 patients and identification of novel and rare alleles. Blood Cells Mol Dis. 2007;38:287\u201393.","journal-title":"Blood Cells Mol Dis"},{"key":"1597_CR11","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/(SICI)1098-1004(1996)7:3<214::AID-HUMU5>3.0.CO;2-A","volume":"7","author":"JW Kim","year":"1996","unstructured":"Kim JW, Liou BB, Lai MY, Ponce E, Grabowski GA. Gaucher disease: identification of three new mutations in the Korean and Chinese (Taiwanese) populations. Hum Mutat. 1996;7:214\u20138.","journal-title":"Hum Mutat"},{"key":"1597_CR12","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1086\/302946","volume":"66","author":"GA Diaz","year":"2000","unstructured":"Diaz GA, Gelb BD, Risch N, Nygaard TG, Frisch A, Cohen IJ, et al. Gaucher disease: the origins of the Ashkenazi Jewish N370S and 84GG acid beta-glucosidase mutations. Am J Hum Genet. 2000;66:1821\u201332.","journal-title":"Am J Hum Genet"},{"key":"1597_CR13","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/BF00216461","volume":"92","author":"N Dahl","year":"1993","unstructured":"Dahl N, Hillborg PO, Olofsson A. Gaucher disease (Norrbottnian type III): probable founders identified by genealogical and molecular studies. Hum Genet. 1993;92:513\u20135.","journal-title":"Hum Genet"},{"key":"1597_CR14","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/cge.13405","volume":"94","author":"JA Ruskey","year":"2018","unstructured":"Ruskey JA, Zhou S, Santiago R, Franche LA, Alam A, Ronci\u00e8re L, et al. The GBA p.Trp378Gly mutation is a probable French-Canadian founder mutation causing Gaucher disease and synucleinopathies. Clin Genet. 2018;94:339\u201345.","journal-title":"Clin Genet"},{"key":"1597_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/cge.12515","volume":"88","author":"RG Chaves","year":"2015","unstructured":"Chaves RG, Pereira Lda V, de Ara\u00fajo FT, Rozenberg R, Carvalho MD, Coelho JC, et al. Consanguinity and founder effect for Gaucher disease mutation G377S in a population from Tabuleiro do Norte, Northeastern Brazil. Clin Genet. 2015;88:391\u20135.","journal-title":"Clin Genet"},{"key":"1597_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12881-019-0759-1","volume":"20","author":"J Sheth","year":"2019","unstructured":"Sheth J, Bhavsar R, Mistri M, Pancholi D, Bavdekar A, Dalal A, et al. Gaucher disease: single gene molecular characterization of one-hundred Indian patients reveals novel variants and the most prevalent mutation. BMC Med Genet. 2019;20:31. https:\/\/doi.org\/10.1186\/s12881-019-0759-1.","journal-title":"BMC Med Genet"},{"key":"1597_CR17","first-page":"447","volume":"60","author":"M Slatkin","year":"1997","unstructured":"Slatkin M, Rannala B. Estimating the age of alleles by use of intrallelic variability. Am J Hum Genet. 1997;60:447\u201358.","journal-title":"Am J Hum Genet"},{"key":"1597_CR18","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/sj.embor.embor873","volume":"4","author":"H Dvir","year":"2003","unstructured":"Dvir H, Harel M, McCarthy AA, Toker L, Silman I, Futerman AH, et al. X-ray structure of human acid-beta-glucosidase, the defective enzyme in Gaucher disease. EMBO Rep. 2003;4:704\u20139.","journal-title":"EMBO Rep"},{"key":"1597_CR19","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1002\/ajh.24063","volume":"90","author":"GA Grabowski","year":"2015","unstructured":"Grabowski GA, Zimran A, Ida H. Gaucher disease types 1 and 3: Phenotypic characterization of large populations from the ICGG Gaucher Registry. Am J Hematol. 2015;90:S12\u20138.","journal-title":"Am J Hematol"},{"key":"1597_CR20","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1086\/302925","volume":"66","author":"V Koprivica","year":"2000","unstructured":"Koprivica V, Stone DL, Park JK, Callahan M, Frisch A, Cohen IJ, et al. Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease. Am J Hum Genet. 2000;66:1777\u201386.","journal-title":"Am J Hum Genet"},{"key":"1597_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1615\/CritRevOncog.2013006060","volume":"18","author":"BE Rosenbloom","year":"2013","unstructured":"Rosenbloom BE, Weinreb NJ. Gaucher disease: a comprehensive review. Crit Rev Oncog. 2013;18:163\u201375.","journal-title":"Crit Rev Oncog"},{"key":"1597_CR22","volume-title":"GeneReviews\u00ae","author":"GM Pastores","year":"1993","unstructured":"Pastores GM, Hughes DA, et al. Gaucher disease. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews\u00ae. Seattle: University of Washington; 1993."},{"key":"1597_CR23","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/s10545-008-0868-z","volume":"31","author":"C Fairley","year":"2008","unstructured":"Fairley C, Zimran A, Phillips M, Cizmarik M, Yee J, Weinreb N, et al. Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease: an analysis of 798 patients from the ICGG Gaucher Registry. J Inherit Metab Dis. 2008;31:738\u201344.","journal-title":"J Inherit Metab Dis"},{"key":"1597_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/ajmg.a.10029","volume":"116A","author":"H Zhao","year":"2003","unstructured":"Zhao H, Bailey LA, Elsas LJ, Grinzaid KA, Grabowski GA. Gaucher disease: in vivo evidence for allele dose leading to neuronopathic and nonneuronopathic phenotypes. Am J Hum Genet. 2003;116A:52\u20136.","journal-title":"Am J Hum Genet"},{"key":"1597_CR25","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1086\/301969","volume":"63","author":"DP Germain","year":"1998","unstructured":"Germain DP, Puech JP, Caillaud C, Kahn A, Poenaru L. Exhaustive screening of the acid beta-glucosidase gene, by fluorescence-assisted mismatch analysis using universal primers: mutation profile and genotype\/phenotype correlations in Gaucher disease. Am J Hum Genet. 1998;63:415\u201327.","journal-title":"Am J Hum Genet"},{"key":"1597_CR26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1203\/01.PDR.0000049515.79882.94","volume":"53","author":"JK Park","year":"2003","unstructured":"Park JK, Orvisky E, Tayebi N, Kaneski C, Lamarca ME, Stubblefield BK, et al. Myoclonic epilepsy in Gaucher disease: genotype-phenotype insights from a rare patient subgroup. Pediatr Res. 2003;53:387\u201395.","journal-title":"Pediatr Res"},{"key":"1597_CR27","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/humu.20676","volume":"29","author":"KS Hruska","year":"2008","unstructured":"Hruska KS, LaMarca ME, Scott CR, Sidransky E. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum Mutat. 2008;29:567\u201383.","journal-title":"Hum Mutat"},{"key":"1597_CR28","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10545-009-9009-6","volume":"33","author":"A Tylki-Szyma\u0144ska","year":"2010","unstructured":"Tylki-Szyma\u0144ska A, Vellodi A, El-Beshlawy A, Cole JA, Kolodny E. Neuronopathic Gaucher disease: demographic and clinical features of 131 patients enrolled in the International Collaborative Gaucher Group Neurological Outcomes Subregistry. J Inherit Metab Dis. 2010;33:339\u201346.","journal-title":"J Inherit Metab Dis"},{"key":"1597_CR29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.braindev.2010.02.005","volume":"33","author":"I Kraoua","year":"2011","unstructured":"Kraoua I, Sedel F, Caillaud C, Froissart R, Stirnemann J, Chaurand G, et al. A French experience of type 3 Gaucher disease: Phenotypic diversity and neurological outcome of 10 patients. Brain Dev. 2011;33:131\u20139.","journal-title":"Brain Dev"},{"key":"1597_CR30","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.pediatrneurol.2014.10.016","volume":"52","author":"M Nagappa","year":"2015","unstructured":"Nagappa M, Bindu PS, Taly AB, Sinha S. Oculomotor apraxia in Gaucher disease. Pediatr Neurol. 2015;52:468\u20139.","journal-title":"Pediatr Neurol"},{"key":"1597_CR31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neulet.2012.02.035","volume":"514","author":"JM Choi","year":"2012","unstructured":"Choi JM, Kim WC, Lyoo CH, Kang SY, Lee PH, Baik JS, et al. Association of mutations in the glucocerebrosidase gene with Parkinson disease in a Korean population. Neurosci Lett. 2012;514:12\u20135.","journal-title":"Neurosci Lett"},{"key":"1597_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13024-019-0336-2","volume":"14","author":"J Do","year":"2019","unstructured":"Do J, McKinney C, Sharma P, Sidransky E. Glucocerebrosidase and its relevance to Parkinson disease. Mol Neurodegener. 2019;14:36. https:\/\/doi.org\/10.1186\/s13024-019-0336-2.","journal-title":"Mol Neurodegener"},{"key":"1597_CR33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2119\/molmed.2017.00023","volume":"23","author":"E Kang","year":"2017","unstructured":"Kang E, Kim YM, Kim GH, Lee BH, Yoo HW, Choi JH. Mutation spectrum of STAR and a founder effect of the p.Q258* in Korean patients with congenital lipoid adrenal hyperplasia. Mol Med. 2017;23:149\u201354.","journal-title":"Mol Med"},{"key":"1597_CR34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12967-015-0624-8","volume":"13","author":"SY Kim","year":"2015","unstructured":"Kim SY, Kim AR, Kim NK, Kim MY, Jeon EH, Kim BJ, et al. Strong founder effect of pP240L in CDH23 in Koreans and its significant contribution to severe-to-profound nonsyndromic hearing loss in a Korean pediatric population. J Transl Med. 2015;13:263. https:\/\/doi.org\/10.1186\/s12967-015-0624-8.","journal-title":"J Transl Med"},{"key":"1597_CR35","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00277-012-1628-6","volume":"92","author":"JY Seo","year":"2013","unstructured":"Seo JY, Song JS, Lee KO, Won HH, Kim JW, Kim SH, et al. Founder effects in two predominant intronic mutations of UNC13D, c.118\u2013308C\u2009>\u2009T and c.754\u20131G\u2009>\u2009C underlie the unusual predominance of type 3 familial hemophagocytic lymphohistiocytosis (FHL3) in Korea. Ann Hematol. 2013;92:357\u201364.","journal-title":"Ann Hematol"},{"key":"1597_CR36","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13023-020-1321-0","volume":"15","author":"YM Kim","year":"2020","unstructured":"Kim YM, Choi JH, Lee BH, Kim GH, Kim KM, Yoo HW. Predominance of the c.648G\u2009>\u2009T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia. Orphanet J Rare Dis. 2020;15:45. https:\/\/doi.org\/10.1186\/s13023-020-1321-0.","journal-title":"Orphanet J Rare Dis"},{"key":"1597_CR37","doi-asserted-by":"crossref","unstructured":"Ferenci P (2006) Regional distribution of mutations \u202cof the ATP7B \u202cgene in \u202cpatients \u202cwith Wilson disease: impact \u202con genetic \u202con genetic testing. Hum \u202cGenet 120:151\u2013159","DOI":"10.1007\/s00439-006-0202-5"},{"key":"1597_CR38","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/jhg.2011.37","volume":"56","author":"SY Jeong","year":"2011","unstructured":"Jeong SY, Kim SJ, Yang JA, Hong JH, Lee SJ, Kim HJ. Identification of a novel recombinant mutation in Korean patients with Gaucher disease using a long-range PCR approach. J Hum Genet. 2011;56:469\u201371.","journal-title":"J Hum Genet"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01597-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-020-01597-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01597-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T07:15:21Z","timestamp":1605078921000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01597-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,11]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1597"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01597-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-41734\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-41734\/v2","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,11]]},"assertion":[{"value":"11 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent was obtained from all patients and their parents, and this study was approved by the Institutional Research Board of each institute. Chungnam National University Hospital IRB No. 2018-07-012. Asan Medical Center IRB No. 2018-0768. Ajou University Hospital IRB No. AJIRB-MED-18-364.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"318"}}